InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-15.5%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by CARROLL J MARTIN, Director. Officer active across 3 companies, notably TherapeuticsMD, Inc.. In total, 16 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €38k. Activity tracked since 28 October 2021. The latest transaction was disclosed on 28 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations16 total
79,873 shares0Common StockSEC:0001628280-26-039520:0
32,734 sharesCommon StockSEC:0000950170-24-137708:0
4,663 shares0Common StockSEC:0001596783-24-000101:0
23,000 shares0Common StockSEC:0001628280-24-025223:0
6,993 shares0Common StockSEC:0001596783-23-000159:0
555 shares0Common StockSEC:0001596783-23-000044:0
5,150 shares0Common StockSEC:0001628280-23-022457:0
8,409 shares@ US$1.491930.4% of flowCommon StockSEC:0001628280-23-017563:0
Ideal exit: 4 Feb 2024 (T+270)
4,149 shares0Common StockSEC:0001596783-22-000163:0
5,000 shares@ US$5.63590.0033% mcap100.0% of flowCommon StockSEC:0001628280-22-016165:0
Ideal exit: 27 Feb 2023 (T+270)
3,136 shares0Common StockSEC:0001596783-21-000194
3,136 shares0Common StockSEC:0001596783-21-000194:0
1,402 shares0Common StockSEC:0001596783-21-000169:0
1,402 shares0Common StockSEC:0001596783-21-000169
96,864 sharesCommon StockSEC:0001387131-21-008434
96,864 sharesCommon StockSEC:0001387131-21-008434:0
16 of 16 declarations
About CARROLL J MARTIN
Martin J. Carroll is a Director at TherapeuticsMD, Inc., Catalent, Inc., and Esperion Therapeutics, Inc. As a board member, he participates in the governance and strategic decision-making for these companies. Martin brings his expertise to help guide their direction, ensuring compliance and performance. His role is essential for the sustainable development of these organizations.
